Biologic and prognostic significance of HER2-low and ER-low expressions in de novo metastatic breast cancer. This is an ASCO Meeting Abstract from the 2024 ASCO Annual Meeting I. This abstract does ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results